MS4A3
Basic information
Region (hg38): 11:60056587-60071115
Previous symbols: [ "CD20L" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the MS4A3 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 14 | 16 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 14 | 2 | 0 |
Variants in MS4A3
This is a list of pathogenic ClinVar variants found in the MS4A3 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
11-60061190-G-T | not specified | Uncertain significance (Jan 27, 2022) | ||
11-60061221-G-C | not specified | Uncertain significance (May 22, 2023) | ||
11-60061308-G-C | not specified | Uncertain significance (May 06, 2022) | ||
11-60062489-G-A | not specified | Uncertain significance (Apr 26, 2023) | ||
11-60062489-G-C | not specified | Uncertain significance (Apr 25, 2022) | ||
11-60062493-T-A | not specified | Uncertain significance (May 23, 2023) | ||
11-60062534-C-G | not specified | Uncertain significance (Apr 20, 2024) | ||
11-60062541-A-G | not specified | Uncertain significance (Oct 17, 2023) | ||
11-60062568-C-T | not specified | Likely benign (Feb 22, 2023) | ||
11-60064262-T-C | not specified | Uncertain significance (Jun 18, 2024) | ||
11-60064278-C-A | not specified | Uncertain significance (Apr 17, 2023) | ||
11-60067039-T-G | not specified | Uncertain significance (Mar 20, 2023) | ||
11-60067040-C-G | not specified | Uncertain significance (Mar 28, 2023) | ||
11-60067086-T-A | not specified | Uncertain significance (Apr 26, 2024) | ||
11-60069581-T-C | not specified | Uncertain significance (Jul 13, 2022) | ||
11-60069619-G-A | not specified | Likely benign (Dec 13, 2021) | ||
11-60069635-T-C | not specified | Uncertain significance (Jan 23, 2024) | ||
11-60069650-A-G | not specified | Uncertain significance (May 03, 2023) | ||
11-60069673-G-A | not specified | Uncertain significance (Apr 29, 2024) | ||
11-60070226-C-T | not specified | Uncertain significance (Sep 30, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
MS4A3 | protein_coding | protein_coding | ENST00000278865 | 6 | 14542 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0000263 | 0.543 | 125727 | 0 | 9 | 125736 | 0.0000358 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.487 | 122 | 108 | 1.13 | 0.00000498 | 1371 |
Missense in Polyphen | 26 | 28.936 | 0.89854 | 371 | ||
Synonymous | 0.615 | 38 | 43.1 | 0.881 | 0.00000225 | 436 |
Loss of Function | 0.655 | 8 | 10.3 | 0.780 | 4.35e-7 | 129 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000248 | 0.000246 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.0000464 | 0.0000462 |
European (Non-Finnish) | 0.0000358 | 0.0000352 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Hematopoietic modulator for the G1-S cell cycle transition. Modulates the level of phosphorylation of cyclin- dependent kinase 2 (CDK2) through its direct binding to cyclin- dependent kinase inhibitor 3 (CDKN3/KAP). {ECO:0000269|PubMed:11781350}.;
- Pathway
- Neutrophil degranulation;Innate Immune System;Immune System
(Consensus)
Recessive Scores
- pRec
- 0.0506
Intolerance Scores
- loftool
- 0.850
- rvis_EVS
- -0.14
- rvis_percentile_EVS
- 43.29
Haploinsufficiency Scores
- pHI
- 0.0731
- hipred
- N
- hipred_score
- 0.123
- ghis
- 0.439
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.000765
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Ms4a3
- Phenotype
Gene ontology
- Biological process
- neutrophil degranulation;regulation of cell cycle
- Cellular component
- plasma membrane;integral component of membrane;specific granule membrane;perinuclear region of cytoplasm
- Molecular function
- protein binding